Fraud and breach of contracts headline the lawsuit Swissray International has filed against Elscint in connection with two distribution agreements executed in August 1998. The suit, filed in the New York Supreme Court, alleges that Elscint violated
Fraud and breach of contracts headline the lawsuit Swissray International has filed against Elscint in connection with two distribution agreements executed in August 1998. The suit, filed in the New York Supreme Court, alleges that Elscint violated agreements to distribute Swissray ddR technology internationally and for Swissray to distribute Elscint imaging equipment in Switzerland. The complaint alleges improprieties in Elscint's negotiation tactics, fraudulent concealment of the impending sale of its imaging businesses, and breaches of the distribution agreements following the sale. Swissray turned to the courts because discussions with Elscint failed to resolve these issues, according to Ruedi G. Laupper, Swissray chairman, president, and CEO. Laupper alleges that the distribution agreement with Elscint markedly delayed the deployment of Swissray technology internationally.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.